Charalampos Tzoulis Selected Research

Spastic Paraplegia Type 7

1/2014	Spastic paraplegia type 7 is associated with multiple mitochondrial DNA deletions.
8/2008	Hereditary spastic paraplegia caused by the novel mutation 1047insC in the SPG7 gene.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Charalampos Tzoulis Research Topics

Disease

19	Parkinson Disease (Parkinson's Disease) 01/2022 - 11/2012
5	Dementia (Dementias) 01/2022 - 01/2018
5	Brain Diseases (Brain Disorder) 01/2021 - 05/2010
3	Cognitive Dysfunction 01/2022 - 08/2015
3	Mitochondrial Diseases (Mitochondrial Disease) 10/2020 - 08/2013
3	Epilepsy (Aura) 11/2017 - 12/2012
3	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2017 - 05/2010
2	Chronic Progressive External Ophthalmoplegia (Progressive External Ophthalmoplegia) 01/2020 - 05/2010
2	Muscular Diseases (Myopathy) 01/2019 - 06/2010
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 11/2016
2	Parkinsonian Disorders (Parkinsonism) 01/2018 - 04/2016
2	Stroke (Strokes) 01/2017 - 02/2009
2	Neoplasms (Cancer) 01/2017 - 04/2015
2	Spastic Paraparesis 04/2015 - 08/2008
2	Spastic Paraplegia Type 7 01/2014 - 08/2008
2	Liver Failure 03/2008 - 07/2006
2	Status Epilepticus (Complex Partial Status Epilepticus) 03/2008 - 07/2006
1	Neurobehavioral Manifestations 11/2021
1	Blepharospasm 01/2021
1	Genomic Instability 01/2021
1	Torticollis (Wryneck) 01/2021
1	Sepsis (Septicemia) 01/2020
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2020
1	Gliosis 01/2020
1	Fatigue 01/2020
1	Sporadic Creutzfeldt-Jakob Disease 01/2020
1	Inclusion Body Myositis 01/2019
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 01/2018
1	Leigh Disease (Leigh's Disease) 01/2018
1	Cardiomyopathies (Cardiomyopathy) 01/2018
1	Ophthalmoplegia (External Ophthalmoplegia) 01/2018
1	Ataxia (Dyssynergia) 01/2018
1	Neuroblastoma 12/2017
1	Synucleinopathies 12/2017
1	Hypoxia (Hypoxemia) 01/2017
1	Multiple Sclerosis 01/2017
1	Relapsing-Remitting Multiple Sclerosis 01/2017
1	Premature Aging 11/2016
1	Basal Ganglia Diseases (Basal Ganglia Disease) 01/2016
1	Erdheim-Chester Disease 04/2015
1	Failure to Thrive 04/2014
1	Myoclonic dystonia 02/2014
1	Seizures (Absence Seizure) 02/2014
1	Dystonia (Limb Dystonia) 05/2013
1	Necrosis 05/2013
1	Peroxisomal Disorders (Peroxisomal Disorder) 01/2013

Drug/Important Bio-Agent (IBA)

15	Mitochondrial DNA (mtDNA)IBA 01/2022 - 02/2009
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2013
4	SynucleinsIBA 01/2022 - 12/2017
3	DNA Polymerase gammaIBA 12/2012 - 05/2010
2	NAD (NADH)IBA 01/2022 - 01/2020
2	Glucosylceramidase (Glucocerebrosidase)IBA 01/2022 - 10/2018
2	Apolipoproteins E (ApoE)IBA 01/2022 - 11/2021
2	nicotinamide-beta-ribosideIBA 01/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2018
2	Adenosine Triphosphate (ATP)IBA 01/2020 - 08/2008
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2017 - 02/2012
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2016 - 08/2013
2	Aspartate-tRNA LigaseIBA 01/2016 - 02/2012
2	Valproic Acid (Depakote)FDA LinkGeneric 03/2008 - 07/2006
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 01/2022
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2022
1	ApolipoproteinsIBA 01/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 11/2021
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2021
1	incobotulinumtoxinA FDA Link 01/2021
1	DNA Glycosylases (DNA Glycosylase)IBA 01/2021
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021
1	Histones (Histone)IBA 01/2021
1	Type A Botulinum Toxins (Botox)FDA Link 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2020
1	LipidsIBA 01/2020
1	Prion ProteinsIBA 01/2020
1	Mitochondrial Proton-Translocating ATPases (Mitochondrial ATP Synthase)IBA 01/2018
1	Opioid Analgesics (Opioids)IBA 01/2018
1	alpha-SynucleinIBA 12/2017
1	Protein AggregatesIBA 12/2017
1	ElementsIBA 11/2017
1	Hypoglycemic Agents (Hypoglycemics)IBA 11/2017
1	Lactate Dehydrogenase 5IBA 01/2017
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2017
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2017
1	Simvastatin (Zocor)FDA LinkGeneric 01/2017
1	EnzymesIBA 01/2017
1	UbiquitinIBA 01/2017
1	Thiamine (Aneurin)FDA Link 01/2016
1	Biotin (Vitamin H)FDA Link 01/2016
1	Ferritins (Ferritin)IBA 08/2015
1	VemurafenibIBA 04/2015
1	Sarcoglycans (beta Sarcoglycan)IBA 02/2014
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2014
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2013
1	AntibodiesIBA 05/2013
1	pristanic acidIBA 01/2013
1	Racemases and Epimerases (Epimerases and Racemases)IBA 01/2013
1	Coenzyme A (CoA)IBA 01/2013

Therapy/Procedure

2	Therapeutics 01/2022 - 04/2015
2	Denervation 01/2018 - 04/2016
1	Institutionalization (Institutionalized Persons) 06/2020
1	Critical Care (Surgical Intensive Care) 04/2014